
Biocon Q2 FY27 Results: Consolidated Net Profit ₹56.70 Crore on Total Income of ₹4,423 Crore
Biocon (NSE: BIOCON) reported consolidated total income of ₹4,423 crore and net profit of ₹57 crore for the quarter ended 30 Sep 2026, it said in a filing on 04 Nov 2026. Standalone total income was ₹721 crore and standalone net profit ₹92 crore for the same quarter.
- Earnings
- Pharmaceuticals and biosimilars









